367 Results for "

Lead optimisation

" in MedChemExpress (MCE) Product Catalog:
Products (367)

367 Results for "Lead optimisation" in MCE Product Catalog:

654
654 Publications Verification
Art. -Nr.: HY-10256
CAS. Nr.: 152121-47-6
Reinheit:  99.92%
Synonyms: SB 203580; RWJ 64809
Adezmapimod (SB 203580) is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2, respectively. Adezmapimod inhibits LCK, GSK3β and PKBα with IC50s of 100-500-fold higher than that for SAPK2a/p38. Adezmapimod can inhibit p38 MAPK and lead to the inhibition of downstream HSP27 phosphorylation. Adezmapimod does not disrupt JNK activity and is an autophagy and mitophagy activator .
loading...
    loading...
61
61 Cited Publications
Art. -Nr.: HY-B0356
CAS. Nr.: 85721-33-1
Synonyms: Bay-09867
Ciprofloxacin (Bay-09867) is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin has anti-proliferative activity and induces apoptosis. Ciprofloxacin is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity .
loading...
    loading...
16
16 Cited Publications
Art. -Nr.: HY-13991
CAS. Nr.: 285986-88-1
Reinheit:  99.88%
Target:  

Ras Apoptosis

Forschungsgebiete:  

Cancer

CCG-1423 is an inhibitor of Rho/MRTF/SRF pathway. CCG-1423 shows activities in several cancer cells. CCG-1423 is a promising lead compound for the development of novel pharmacologic tools, and it can be used for the research of cancer and diabetes .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-P0203
CAS. Nr.: 83651-90-5
Synonyms: CGRP (83-119), mouse, rat
α-CGRP (mouse, rat), a neuropeptide (calcitonin gene-related peptide (CGRP)) mainly expressed in neuromuscular junction, is a potent vasodilator. α-CGRP (mouse, rat) can lead to a fall in blood pressure and an increase in heart rate by peripheral administration, also relax colonie smooth muscle. α-CGRP (mouse, rat) has the potential in cardiovascular, pro-inflammatory, migraine and metabolic studies .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-P0203A
Synonyms: CGRP (83-119), mouse, rat TFA
α-CGRP (mouse, rat) TFA, a neuropeptide (calcitonin gene-related peptide (CGRP)) mainly expressed in neuromuscular junction, is a potent vasodilator. α-CGRP (mouse, rat) TFA can lead to a fall in blood pressure and an increase in heart rate by peripheral administration, also relax colonie smooth muscle. α-CGRP (mouse, rat) TFA has the potential in cardiovascular, pro-inflammatory, migraine and metabolic studies .
loading...
    loading...
8
8 Cited Publications
Art. -Nr.: HY-P1068
CAS. Nr.: 9001-63-2
Synonyms: Muramidase
Lysozyme (Muramidase) is a conserved antimicrobial protein. Lysozyme exerts its bactericidal effect by hydrolyzing bacterial cell wall peptidoglycan (PG). Lysozyme plays an important role in limiting bacterial growth on mucosal surfaces and other sites, not only controlling potential pathogens but also limiting overgrowth of microbiota to prevent dysbiosis. Extracellular lysozyme can also degrade polymeric PG into soluble fragments, activate NOD receptors in mucosal epithelial cells, and lead to the secretion of chemokines and activating factors by neutrophils and macrophages .
loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-P99731
CAS. Nr.: 899796-83-9
Synonyms: hLL1; MEDI-115

Target:  

CD74

Forschungsgebiete:  

Cancer

Milatuzumab (hLL1; MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-100226
CAS. Nr.: 251992-66-2
Reinheit:  98.25%
Target:  

Integrin

Forschungsgebiete:  

Inflammation/Immunology

A-205804 is an orally bioavailable, potent and selective lead inhibitor of E-selectin and ICAM-1 expression, with an IC50 of 20 nM and 25 nM for E-selectin and ICAM-1, respectively. A-205804 can be used in the research of chronic inflammatory diseases .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-N0498
CAS. Nr.: 13063-04-2
Nitidine chloride, a potential anti-malarial lead compound derived from Zanthoxylum nitidum (Roxb) DC, exerts potent anticancer activity through diverse pathways, including inducing apoptosis, inhibiting STAT3 signaling cascade, DNA topoisomerase 1 and 2A, ERK and c-Src/FAK associated signaling pathway, also has anti-inflammatory activity. Nitidine chloride inhibits LPS-induced inflammatory cytokines production via MAPK and NF-kB pathway .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-N0596
CAS. Nr.: 19666-76-3
Synonyms: 20(R)-Panaxadiol
Panaxadiol (20(R)-Panaxadiol) is an orally active HIF-1α/STAT3 inhibitor. Panaxadiol can suppress HIF-1α and STAT3 then lead to downregulation of programmed cell death-ligand 1 (PD-L1) expression. Panaxadiol shows anticancer, cardioprotective, anti-arrhythmic, and antioxidative activities .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-Y0061
CAS. Nr.: 59-48-3
Synonyms: 2-Indolinone
Oxindole (Indolin-2-one) is an aromatic heterocyclic building block. 2-indolinone derivatives have become lead compounds in the research of kinase inhibitors.
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-Y0351
CAS. Nr.: 103-85-5
Synonyms: Phenylthiocarbamide
Forschungsgebiete:  

Others

Phenylthiourea (Phenylthiocarbamide) is an inhibitor for phenoloxidase. Phenylthiourea inhibits enzymatic oxidation of DOPA by phenoloxidase (Ki = 0.21 μM). Phenylthiourea is an effective inhibitor for tyrosinase. Phenylthiourea can lead to graying of hair in black rats due to the interference with melanin formation .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-143228
CAS. Nr.: 2143952-36-5
Reinheit:  99.80%
Target:  

SARS-CoV

SH-42 is a potent and selective inhibitor of human Δ 24-dehydrocholesterol reductase (DHCR24), with an IC50 of 42 nM. SH-42 can lead to a significant increase in plasma desmosterol levels of mice .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-Y0525
CAS. Nr.: 2997-92-4
Synonyms: 2,2'-Azodiisobutyramidine dihydrochloride
Forschungsgebiete:  

Inflammation/Immunology

AAPH (2,2'-Azodiisobutyramidine dihydrochloride) has an effect of radical generation. AAPH induces oxidative stress and erythrocyte hemolysis . AAPH decomposes at 37°C to generate an alkyl radical, is used as an initiator. In the presence of oxygen, these alkyl radicals will be converted to peroxyl radicals that can cause lipid peroxidation and loss of erythrocyte membrane integrity, which could ultimately lead to hemolysis .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-163731
CAS. Nr.: 3077196-25-6
EGR-1-IN-1 is a EGR-1 inhibitor with an IC50 of 1.86 μM. EGR-1-IN-1 binds to the zinc finger DNA-binding domain of EGR-1 and promotes the dissociation of the EGR-1-DNA complex. EGR-1-IN-1 reduces the mRNA expression levels of EGR-1-regulated inflammatory genes induced by TNFα. EGR-1-IN-1 alleviates atopic dermatitis-like lesions in the ear skin of mice. EGR-1-IN-1 serves as a lead compound for the development of targeted compounds for inflammatory skin diseases. EGR-1-IN-1 can be used in studies related to atopic dermatitis .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-139399
CAS. Nr.: 2230273-76-2
Reinheit:  99.63%
Synonyms: JNJ-67856633
Target:  

MALT1

Forschungsgebiete:  

Cancer

Safimaltib (JNJ-67856633) is an orally active, first-in-class, potent, selective and allosteric MALT1 protease inhibitor. Safimaltib in some cases lead to tumor stasis .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-145963
CAS. Nr.: 2863686-81-9
Reinheit:  99.58%
Target:  

GLUT

Forschungsgebiete:  

Cancer

DRB18 is a potent pan-class GLUT inhibitor. DRB18 alters energy-related metabolism in A549 cells by changing the abundance of metabolites in glucose-related pathways. DRB18 can eventually lead to G1/S phase arrest and increase oxidative stress and necrotic cell death. DRB18 has anti-tumor activity .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-128204
CAS. Nr.: 1268335-33-6
Reinheit:  99.89%
Target:  

Parasite

Forschungsgebiete:  

Infection

AN3661, a potent antimalarial lead compound, targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue subunit 3 (PfCPSF3). AN3661 inhibits Plasmodium falciparum laboratory-adapted strains (mean IC50=32 nM), Ugandan field isolates (mean ex vivo IC50=64 nM), and murine P. berghei and P. falciparum infections .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-109520
CAS. Nr.: 147245-92-9
Reinheit:  ≥98.0%
Target:  

MHC

Forschungsgebiete:  

Inflammation/Immunology Cancer

Glatiramer acetate, a synthetic analogue of myelin basic protein and an immunomodulating agent, inhibits Experimental autoimmune encephalomyelitis (EAE), and can be used for the research of multiple sclerosis. Glatiramer acetate exhibits strong and promiscuous binding to MHC molecules and consequent competition with various myelin antigens for their presentation to T cells. A further aspect of its action is potent induction of specific suppressor cells of the T helper 2 (Th2) type that migrate to the brain and lead to in situ bystander suppression .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-136379
CAS. Nr.: 1222513-26-9
Reinheit:  99.84%
Synonyms: Cdc42-IN-1
Target:  

Ras

Forschungsgebiete:  

Cancer

CID44216842 (Cdc42-IN-1) is a potent Cdc42-selective guanine nucleotide binding lead inhibitor. The EC50s for Cdc42 WT and Cdc42Q61L mutant are 1.0 and 1.2 μM in GTP binding assay, respectively. The EC50s for Cdc42 WT and Cdc42Q61L mutant are 0.3 and 0.5 μM in GDP binding assay, respectively. Use as a molecular probe .
loading...
    loading...